The Emerging Role of Poly (ADP-Ribose) Polymerase Inhibitors as Effective Therapeutic Agents in Renal Cell Carcinoma

Renal cell carcinoma (RCC) is the sixth most common cancer in the US. However, no significant changes in management have occurred since the tyrosine kinase era until the recent breakthrough with checkpoint inhibitors. Therefore, the need for more therapeutic options is paramount. Our objective was t...

Descripción completa

Detalles Bibliográficos
Autores principales: Pletcher, Jerred P., Bhattacharjee, Sayani, Doan, Jonathan P., Wynn, Rebecca, Sindhwani, Puneet, Nadiminty, Nagalakshmi, Petros, Firas G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8300201/
https://www.ncbi.nlm.nih.gov/pubmed/34307148
http://dx.doi.org/10.3389/fonc.2021.681441

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8300201/
https://www.ncbi.nlm.nih.gov/pubmed/34307148
http://dx.doi.org/10.3389/fonc.2021.681441

Ejemplares similares